We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$4.08B
AUM Growth
–
Cap. Flow
+$4.13B
Cap. Flow
% of AUM
101.22%
Top 10 Holdings %
Top 10 Hldgs %
8.91%
Holding
1,458
New
1,458
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$54.8M |
| 2 |
Eli Lilly
LLY
|
+$53.2M |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$40.7M |
| 4 |
Conagra Brands
CAG
|
+$39.9M |
| 5 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$32.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.53% |
| 2 | Financials | 12.45% |
| 3 | Industrials | 11.63% |
| 4 | Healthcare | 11.27% |
| 5 | Technology | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
51
DELISTED
QVC Group Inc Series A
QVCGA
| $14M | 0.34% |
+14,845
| New | +$13.4M |
|
52
Oneok
OKE
$58.7B
| $14M | 0.34% |
+386,639
| New | +$15.9M |
|
53
Colgate-Palmolive
CL
$72.6B
| $13.9M | 0.34% |
+241,834
| New | +$14.4M |
|
54
Apple
AAPL
$4.89T
| $13.7M | 0.34% |
+968,800
| New | +$14.9M |
|
55
VanEck Gold Miners ETF
GDX
$23B
| $13.3M | 0.33% |
+545,300
| New | +$15.9M |
|
56
Lam Research
LRCX
$382B
| $12.9M | 0.32% |
+2,899,820
| New | +$13.1M |
|
57
United Airlines
UAL
$38.4B
| $12.7M | 0.31% |
+407,278
| New | +$13M |
|
58
Abbott
ABT
$180B
| $12.6M | 0.31% |
+361,472
| New | +$13.3M |
|
59
Visa
V
$677B
| $12.5M | 0.31% |
+274,576
| New | +$12M |
|
60
Accenture
ACN
$89.9B
| $12.3M | 0.3% |
+171,285
| New | +$13.6M |
|
61
Merck
MRK
$324B
| $12.3M | 0.3% |
+276,608
| New | +$12.4M |
|
62
Capri Holdings
CPRI
$1.77B
| $12.2M | 0.3% |
+196,385
| New | +$11.5M |
|
63
Ulta Beauty
ULTA
$20.4B
| $11.9M | 0.29% |
+119,116
| New | +$10.7M |
|
64
Marathon Petroleum
MPC
$90.3B
| $11.9M | 0.29% |
+333,564
| New | +$13.3M |
|
65
Herc Holdings
HRI
$5.43B
| $11.8M | 0.29% |
+158,733
| New | +$11.6M |
|
|
RDS.B
66
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $11.7M | 0.29% |
+176,998
| New | +$12.1M |
|
67
AstraZeneca
AZN
$263B
| $11.6M | 0.28% |
+245,207
| New | +$12.5M |
|
68
Bank of America
BAC
$435B
| $11.5M | 0.28% |
+893,900
| New | +$11.4M |
|
69
American Tower
AMT
$77.7B
| $11.4M | 0.28% |
+155,241
| New | +$12.4M |
|
70
Agilent Technologies
A
$39.1B
| $11.4M | 0.28% |
+371,138
| New | +$11.5M |
|
71
General Dynamics
GD
$105B
| $11.2M | 0.27% |
+142,753
| New | +$10.6M |
|
72
Moody's
MCO
$81.7B
| $11.1M | 0.27% |
+181,922
| New | +$11M |
|
73
Johnson Controls International
JCI
$87.5B
| $11M | 0.27% |
+293,948
| New | +$11M |
|
74
American Electric Power
AEP
$73.7B
| $10.9M | 0.27% |
+243,589
| New | +$11.7M |
|
75
SLM Corp
SLM
$4.57B
| $10.8M | 0.27% |
+1,325,340
| New | +$10.3M |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
WAS
SGI
AAM
PDT Partners's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for PDT Partners, which disclosed 1,458 positions worth $4.08B. Its ten largest holdings account for 8.9% of the portfolio.
Its largest position is Allergan Inc: 528,280 shares worth $44.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, followed by Financials and Industrials.
- PDT Partners's largest Q2 2013 buy was Allergan Inc: 528,280 shares worth $44.5M.
- PDT Partners's ten largest holdings make up 8.9% of its $4.08B portfolio in Q2 2013.
- PDT Partners disclosed 1,458 positions in Q2 2013, its first 13F filing on record.
Based on PDT Partners's 13F filing for Q2 2013, filed 14 Aug 2013.